From the National Institute of Allergy and Infectious Diseases. Summary of an International Symposium on potentiation of the immune response to vaccines.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000276:immunology; D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000096:biosynthesis / Q000276:immunology / Q000627:therapeutic use; D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D006193:Haemophilus influenzae / Q000276:immunology; D000882:Haplorhini; D006801:Humans; D007114:Immunization; D007223:Infant; D007252:Influenza Vaccines / Q000276:immunology; D008213:Lymphocyte Activation; D051379:Mice; D009161:Mycobacterium / Q000276:immunology; D011119:Polynucleotides / Q000276:immunology; D014612:Vaccines / Q000276:immunology*
D000276:Adjuvants, Immunologic; D001323:Autoantibodies; D007252:Influenza Vaccines; D011119:Polynucleotides; D014612:Vaccines; D000119:Acetylmuramyl-Alanyl-Isoglutamine